Literature DB >> 28315943

Hyperoxia Reduces Oxygen Consumption in Children with Pulmonary Hypertension.

Long Guo1,2, Prashant Bobhate1,2,3, Shine Kumar1,2,4, Karunakar Vadlamudi1,2, Tarek Kaddoura5, Mohamed Elgendi6,7, Paula Holinski1,2,8, James Y Coe9, Jennifer Rutledge9, Ian Adatia10,11,12.   

Abstract

High inspired oxygen concentration (FiO2 > 0.85) is administered to test pulmonary vascular reactivity in children with pulmonary hypertension (PH). It is difficult to measure oxygen consumption (VO2) if the subject is breathing a hyperoxic gas mixture so the assumption is made that baseline VO2 does not change. We hypothesized that hyperoxia changes VO2. We sought to compare the VO2 measured by a thermodilution catheter in room air and hyperoxia. A retrospective review of the hemodynamic data obtained in children with PH who underwent cardiac catheterization was conducted between 2009 and 2014. Cardiac index (CI) was measured by a thermodilution catheter in room air and hyperoxia. VO2 was calculated using the equation CI = VO2/arterial-venous oxygen content difference. Data were available in 24 subjects (males = 10), with median age 8.3 years (0.8-17.6 years), weight 23.3 kg (7.5-95 kg), and body surface area 0.9 m2 (0.4-2.0 m2). In hyperoxia compared with room air, we measured decreased VO2 (154 ± 38 to 136 ± 34 ml/min/m2, p = 0.007), heart rate (91 [Formula: see text] 20 to 83 [Formula: see text] 21 beats/minute, p=0.005), mean pulmonary artery pressure (41 [Formula: see text] 16 to 35 [Formula: see text] 14 mmHg, p=0.024), CI (3.6 [Formula: see text] 0.8 to 3.3 [Formula: see text] 0.9 L/min/m2, p = 0.03), pulmonary vascular resistance (9 [Formula: see text] 6 to 7 [Formula: see text] 3 WU m2, p = 0.029), increased mean aortic (61 [Formula: see text] 11 to 67 [Formula: see text] 11 mmHg, p = 0.005), pulmonary artery wedge pressures (11 [Formula: see text] 8 to 13 [Formula: see text] 9 mmHg, p = 0.006), and systemic vascular resistance (12 [Formula: see text] 6 to 20 [Formula: see text] 7 WU m2, p=0.001). Hyperoxia decreased VO2 and CI and caused pulmonary vasodilation and systemic vasoconstriction in children with PH. The assumption that VO2 remains unchanged in hyperoxia may be incorrect and, if the Fick equation is used, may lead to an overestimation of pulmonary blood flow and underestimation of PVRI.

Entities:  

Keywords:  Cardiac catheterization; Hyperoxia; Oxygen consumption; Pulmonary hypertension; Pulmonary vasoreactivity; Thermodilution

Mesh:

Year:  2017        PMID: 28315943     DOI: 10.1007/s00246-017-1602-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  17 in total

1.  Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance.

Authors:  J M Neutze; T Ishikawa; P M Clarkson; A L Calder; B G Barratt-Boyes; A R Kerr
Journal:  Am J Cardiol       Date:  1989-02-01       Impact factor: 2.778

2.  Measurement of oxygen consumption in children undergoing cardiac catheterization: comparison between mass spectrometry and the breath-by-breath method.

Authors:  Long Guo; Yong Cui; Scott Pharis; Mark Walsh; Joseph Atallah; Meng-Wei Tan; Jennifer Rutledge; J Y Coe; Ian Adatia
Journal:  Pediatr Cardiol       Date:  2013-12-19       Impact factor: 1.655

3.  Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?

Authors:  A Bush; C Busst; K Booth; W B Knight; E A Shinebourne
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

4.  Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.

Authors:  Kevin D Hill; D Scott Lim; Allen D Everett; D Dunbar Ivy; J Donald Moore
Journal:  Catheter Cardiovasc Interv       Date:  2010-11-15       Impact factor: 2.692

5.  Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.

Authors:  A M Atz; I Adatia; J E Lock; D L Wessel
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

6.  Revisiting the role of oxygen therapy in cardiac patients.

Authors:  Raman Moradkhan; Lawrence I Sinoway
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

7.  The cardiovascular effects of normobaric hyperoxia in patients with heart rate fixed by permanent pacemaker.

Authors:  K J Anderson; J M Harten; M G Booth; C Berry; A McConnachie; A C Rankin; J Kinsella
Journal:  Anaesthesia       Date:  2009-12-01       Impact factor: 6.955

8.  Cardiovascular effects of acute oxygen administration in healthy adults.

Authors:  W Stephen Waring; Alastair J Thomson; Sunil H Adwani; Arendi J Rosseel; John F Potter; David J Webb; Simon R J Maxwell
Journal:  J Cardiovasc Pharmacol       Date:  2003-08       Impact factor: 3.105

9.  The use of oxygen and prostacyclin as pulmonary vasodilators in congenital heart disease.

Authors:  A Bush; C M Busst; E A Shinebourne
Journal:  Int J Cardiol       Date:  1985-11       Impact factor: 4.164

10.  Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): the INOP Test Study Group.

Authors:  David T Balzer; Henry W Kort; Ronald W Day; Howard M Corneli; John P Kovalchin; Bryan C Cannon; Stephen F Kaine; D Dunbar Ivy; Steven A Webber; Abraham Rothman; Robert D Ross; Sanjeev Aggarwal; Masato Takahashi; J Deane Waldman
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

View more
  1 in total

Review 1.  Pediatric Perioperative Pulmonary Arterial Hypertension: A Case-Based Primer.

Authors:  Shilpa Shah; Jacqueline R Szmuszkovicz
Journal:  Children (Basel)       Date:  2017-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.